Analysts Say AI Could Add $100B+ to Healthcare—But Most Systems Aren't Ready
Issued on behalf of Avant Technologies Inc.
VANCOUVER – Baystreet.ca News Commentary – A growing chorus of political and academic voices is calling AI the defining force behind the next evolution in healthcare. Former UK Prime Minister Tony Blair recently warned that failing to embrace AI-driven doctors and nurses could leave entire nations behind, while London Business School professor Nicos Savva echoed the sentiment in Forbes, framing AI as essential to future-ready care. Meanwhile, a new Wolters Kluwer report highlights a troubling disconnect: while interest is surging, most healthcare organizations remain unprepared to deploy GenAI tools at scale. Yet even as institutions scramble to catch up, key breakthroughs are already coming from innovators like Avant Technologies, Inc. (OTCQB: AVAI), Palantir Technologies (NASDAQ: PLTR), Astrana Health, Inc. (NASDAQ: ASTH), Tempus AI, Inc. (NASDAQ: TEM), and SoundHound AI, Inc. (NASDAQ: SOUN).
Analysts at McKinsey now estimate that generative AI could generate up to $110 billion in annual value across pharma and medical products alone. Statista projects the broader AI healthcare market will surge from $11 billion today to $188 billion by 2030 — a leap that signals just how quickly the landscape is changing.
Avant Technologies, Inc. (OTCQB: AVAI) has just taken a major step forward in its evolution from AI incubator to full-stack healthcare innovator. Today, the company announced it had signed a non-binding letter of intent to acquire 100% of Ainnova Tech, its joint venture partner and the developer of the Vision AI diagnostic platform. Prior to the acquisition, the two companies have been operating jointly through Ai-nova Acquisition Corp (AAC), which holds global licensing rights to Ainnova's technology portfolio and serves as the commercialization engine for Vision AI and all future device deployments.
'We believe bringing the two companies together will offer tremendous value for shareholders, it will simplify the process of advancing our technology to market, and it will deliver value to our customers and partners as we promote our technology portfolio globally,' said Vinicio Vargas, CEO at Ainnova and a member of the Board of Directors of AAC. 'We feel the joint venture has been a success and both companies have worked well together toward a common goal, so we believe that we can be even more successful and use our resources more effectively as one company to further AI in healthcare.'
Under the proposed agreement, Ainnova would roll all of its outstanding equity into the combined public entity — unifying leadership and eliminating structural complexity ahead of a scheduled FDA pre-submission meeting in July.
While final terms of the deal are still being negotiated, both companies say the merger would streamline commercialization and accelerate the rollout of Ainnova's flagship Vision AI technology — a platform already in use across clinical sites in Latin America for the early detection of diabetic retinopathy, cardiovascular disease, and other chronic conditions. The move also signals growing confidence from Avant's leadership as they prepare to bring proprietary hardware into the mix.
In parallel with the merger discussions, Avant and Ainnova are entering the final prototyping stage of a low-cost, automated retinal imaging device — marking a potential turning point in the companies' shared push toward AI-powered early diagnostics.
The new device is designed to operate hands-free and feed imaging data directly into the Vision AI platform, enabling near-instant risk reports without expensive equipment or trained personnel.
The companies say the camera, developed under their joint venture Ai-nova Acquisition Corp. (AAC), is expected to cost a fraction of legacy fundus cameras. By combining affordability with automation, the device could expand screening access across primary care clinics and emerging-market providers that have traditionally been priced out of ophthalmic diagnostics.
'The cost of a fundus camera has always been a barrier to entry in this market,' said Vargas. 'Our low-cost camera, which is a fraction of the cost of currently available cameras on the market, should allow us to not only enter the market, but to capture a large share of the market.'
Also in development are additional platform modules, including a patented dementia detection tool that combines a five-minute blood test with AI-trained algorithms. Although that technology remains in evaluation, the core platform continues to expand its reach and functionality — evolving from a retinal-focused application into a broader engine for predictive healthcare.
'Our purpose is to create the future of early disease detection in an accessible way, so that patients can get a preventive check-up anywhere, at a low cost, and easily,' said Vargas in a previous statement. 'We want to prevent patients with risk factors from developing other diseases that could have been avoided before they became a real problem. To this end, we are seeking to integrate new technologies into our portfolio within a single platform, both through our R&D efforts and through potential exclusive licenses or acquisitions.'
As the camera prototype nears completion, Avant is positioning itself for broader market entry. While a launch date has yet to be announced, the integrated platform is designed to reduce diagnostic friction, speed up referrals, and expand access to early-stage health insights — especially in geographies where affordability, not innovation, remains the primary barrier to care.
Palantir Technologies (NASDAQ: PLTR) has partnered with TeleTracking Technologies to bring real-time AI-driven insights to hospitals and health systems.
'This partnership with TeleTracking represents the AI revolution in healthcare we are in the midst of—where we continue to move closer to a world where all hospitals and health systems are embracing, implementing and operating with an AI-powered approach,' said Alex Karp, CEO at Palantir. 'Helping to streamline operations allowing for increased focus on providing the best level of care.'
By integrating TeleTracking's Operations IQ platform with Palantir's Foundry and AIP tools, the collaboration will enable smarter resource management, predictive forecasting, and near-instant operational decision-making.
The combined platform is designed to improve patient flow, reduce staff burden, and drive measurable gains in both care outcomes and financial performance.
Astrana Health, Inc. (NASDAQ: ASTH) recently announced a wave of leadership appointments as the company accelerates its national rollout of an AI-driven, value-based care model. The most notable addition is Sherry McBride, a seasoned Medicare Advantage operator who joins as COO to lead integration and execution across Astrana's growing platform.
'We are thrilled to welcome Sherry, along with other recent executive hires and promotions, to the leadership team at a time of immense growth and opportunity for Astrana,' said Brandon Sim, President and CEO of Astrana Health. 'Her deep experience in delegated value-based care will further strengthen our ability to drive consistent, coordinated, high-quality patient outcomes at scale.'
Other hires include a new Chief Data and Analytics Officer, Chief Accounting Officer, and Chief People Officer — a signal of Astrana's broader push to deepen capabilities across every operational tier. With a footprint spanning over 12,000 providers and more than a million patients, Astrana is preparing to scale smart, coordinated care on a national level.
Tempus AI, Inc. (NASDAQ: TEM) has expanded its generative AI clinical assistant, Tempus One, with direct integration into EHR systems, allowing physicians to query data and streamline workflows in real time.
'As healthcare faces rising costs and growing complexity, no group bears the burden more heavily than physicians and care teams,' said Ryan Fukushima, Chief Operating Officer at Tempus. 'This evolution of Tempus One represents a meaningful shift from a world where clinicians spend countless hours searching for answers and documenting care, to one where AI rapidly connects the dots across fragmented systems to deliver actionable insights in real time.'
The platform now includes embedded ASCO guidelines, appointment prep tools, and intelligent note-taking — reducing administrative burden and improving decision-making in oncology and beyond. Tempus is also rolling out its Agent Builder tool to select providers, enabling custom GenAI solutions integrated directly into clinical practice.
SoundHound AI, Inc. (NASDAQ: SOUN) has partnered with Allina Health to launch 'Alli,' an AI-powered voice agent designed to streamline patient access and reduce administrative bottlenecks.
"One of our key goals is to make sure that we're providing a market-leading patient experience," said David Ingham, DO, Chief Information Officer of Allina Health. "Alli is an extension of our team, and we're excited to have her on board to streamline operations, reduce wait times, and deliver a faster, more seamless experience for our patients."
Built on the Amelia conversational AI platform, Alli integrates with Allina's EHR system to authenticate callers, manage appointments, and soon handle tasks like refilling medications or answering non-clinical questions.
"Long wait times and administrative complexity can be a huge source of stress for patients," said Michael Anderson, Executive Vice President of Enterprise AI at SoundHound AI. "We are proud to partner with Allina Health on this important digital transformation. The organization is taking a forward-thinking approach by integrating AI to support patients with immediate, personalized assistance."
Early results show improved call efficiency and faster response times, enabling staff to focus on complex patient needs.
CONTACT:
Baystreet.ca
cs@baystreet.ca
(250) 999-4849
DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Baystreet.ca is a wholly-owned subsidiary of Baystreet.ca Media Corp. ('BAY') BAY has been not been paid a fee for Avant Technologies Inc. advertising and/or digital media, but the owner(s) of BAY also own Market IQ Media Group, Inc., which has been paid a fee from the company directly. There may be 3rd parties who may have shares Avant Technologies Inc., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of BAY own shares of Avant Technologies Inc. which were purchased in the open market. BAY and all of it's respective employees, owners and affiliates reserve the right to buy and sell, and will buy and sell shares of Avant Technologies Inc. at any time thereafter without any further notice. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material disseminated by BAY has been approved by the above mentioned company; this is a paid advertisement, and we own shares of the mentioned company that we will sell, and we also reserve the right to buy shares of the company in the open market, or through other investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBC
32 minutes ago
- CBC
Soldiers from N.B. serving near Russia return home to increased defence spending
Another six-month rotation of Canadian soldiers in Latvia is coming to an end, and two soldiers from New Brunswick will be among the troops coming home to the news that Canada is increasing and accelerating investments in defence. Lt.-Col. Jacques Pinard and Chief Warrant Officer Jean Sebastien Morin have both been serving among the 2,000 Canadian troops stationed in Latvia, where they're defending the eastern flank of NATO. Based at Camp Adazi, about an hour's drive from the Russian border, they're tasked with protecting a population that lives in a state of vigilance. "There are cameras on every corner," Pinard said. "You can't go anywhere in Latvia without being recorded. And it's accepted by the Latvian public that this is just a thing that's there to provide safety for everyone." The war between Ukraine and Russia is never far from their thoughts, he said. "For instance, drones that are flying around, those are taken very seriously if they haven't been approved prior to having them up in the air, so that is very tightly controlled," Pinard said. On Monday, Prime Minister Mark Carney pledged an extra $9 billion this fiscal year to strengthen existing and emerging military capabilities. That includes money to accelerate recruitment. The goal is to bring the Canadian Armed Forces to 71,500 regular and 30,000 primary reserve members by 2030. That's an increase of 13,000 members. Military personnel will also get pay raises. Some new hires may find themselves in Latvia, where Canada's commitment has no end date. The first 100 Canadian soldiers arrived there in 2017, and now Canada leads an international brigade, supported by 14 countries, including NATO's newest member, Sweden. Less than a year after joining NATO, Sweden sent hundreds of troops to join the battle group in February. Soldiers focused on improving health care Providing health care on site is part of Canada's growing responsibility in Latvia. A multidisciplinary health-care team that includes doctors, nurses, a dental team, social workers, physiotherapists and a pharmacy, is expected to expand. "We're definitely looking after a much larger group of individuals from different nations," Morin said in his role as the regimental sergeant major for the multinational medical units. He said Canada is also working to increase its ability to provide medical care to soldiers in the field. "The medical capacity we're trying to build is, well, I would put it as bringing health care as far forward as possible in the battle space," he said. "We will definitely bring everything to where it needs to be and strategically placed so we can ensure the personnel who are injured have the best chance of survival." The Canadians have been leading various military practice exercises, including a simulated response to mass casualty events. New investment good for morale Canada's new spending is sure to benefit all Canadian military bases and boost troop morale, said Christian Leuprecht, a professor at the Royal Military College of Canada. "The prime minister's announcement specifically mentions armoured vehicle and artillery pieces, both of which the Canadian Armed Forces are desperately short on, and are in high demand at [CFB] Gagetown," Leuprecht said from Riga, Latvia, where he's attending a NATO conference on strategic communications. Meanwhile, as long as conflict prevails in Ukraine, Leuprecht said, it's less likely that Russia will have the capacity to focus its aggression elsewhere. That could change quickly, however, if the fighting stops, he said. "If [Putin] sets his sights on a country, chances are it's going to be one of the three smallest countries in the alliance, that being Estonia, Latvia or Lithuania," Leuprecht said. "And Latvia is the country that has the largest Russian-speaking minority and the direct border. So it has always been a very high risk place." It will take several flights over the next few weeks to repatriate Canadian soldiers who are winding up their deployment. Pinard said he'll be returning to New Brunswick to pick up his family and move them to Edmonton. Morin said he hopes to visit family in northern New Brunswick. Neither could be reached for comment on the new spending announcement. A media relations officer at the Department of National Defence was unable to say how the pledge to bring defence spending up to the NATO target of two per cent of Canada's gross domestic product will impact the mission in Latvia, called Operation Reassurance.
CBC
32 minutes ago
- CBC
Province will spend $6.5M to keep paramedic, EMT graduates in N.B.
Social Sharing The province has announced a $6.5-million bursary program for paramedic and emergency medical technician students that train in New Brunswick and commit to working in the province. The program will be available to current and future students until March 2026. To be eligible, paramedics must sign a two-year agreement and emergency medical technicians will need to sign a one-year agreement. Students will then be reimbursed in two payments — the first when they finish school and the second when they complete their "return-of-service" agreement. Craig Dalton, the CEO of EM/ANB Inc., previously known as Ambulance New Brunswick, said the funding will address current staffing shortages and, in turn, reduce the pressure on staff. "The reality of serving today … is that doing what they do in a system that has been beset with staffing shortages is a challenge and it takes a toll," Dalton said. The funding will cover the full cost of training for 273 paramedics and 39 EMT students. Of the paramedics, 75 are currently enrolled and up to 198 would start training in the 2025-26 academic year. WATCH | Reimbursement will help work-life balance, Ambulance N.B. CEO says: Paramedic, EMT students to get tuition money back if they work in N.B. 2 hours ago Duration 2:10 New Brunswick is putting $6.5 million into a tuition reimbursement fund for paramedic and emergency medical technician students who promise to work in the province after they graduate. Health Minister John Dornan said the province is "down by about 200" staff and this recruitment effort will help create a "more comfortable working environment." "We need to have more paramedics and EMTs on the road and this initiative will help ensure there's a pipeline of trained professionals training here to help fulfil current and future vacancies," Dornan said. Dalton said staffing struggles are "like any other health-care profession." "It's been that way for five plus years. So, it's a challenge to get that very small group of talent, and this is a huge tool in our toolbox to be able to do that," he said. Dornan said the role of paramedics is evolving, and the services they provide continue to expand. "It's tougher to be a paramedic today than it was 20 years ago," said Dornan, a doctor and former Horizon Health CEO. He said paramedics are able to put tubes into people's lungs and defibrillate patients in the ambulance. He said the province is also working to allow paramedics to give "clot busters" in the ambulance to help people survive heart attacks. "The ability, the tools that paramedics can use now are way more than they were in the past and they want this, they're asking us to let them do more." In the future, he said paramedics will be "very integrated" with the province's collaborative care teams. "Sometimes a paramedic will come to your door and you might not need to go to the hospital," Dornan said. Dalton said seven additional ambulance units will be introduced across the province this year, "in areas where we are particularly stressed with the services." Ambulance New Brunswick will also work with the province to rethink how units are dispatched. "My message is the system needs to evolve as the environment evolves, and I'm confident that we're doing that," Dalton said. Rebecca Bird has been a paramedic for three years and loves her job, despite it being difficult at times. She attended the announcement in Moncton and is glad the province is helping students. She said she would've liked the same opportunity during her training. According to Medavie HealthEd's website, the 50-week primary care paramedic program costs approximately $21,000. Bird looks forward to having more staff in the province to improve the lives of current staff. "It's really going to help staff our trucks, ensure that we're getting off on time … we're going to be able to help our other colleagues with covering what needs to be covered and hopefully giving us that work-life balance that we desperately need." According to a news release from the province, the program covers training offered by Omni Life Support Training & Consulting, Medavie HealthEd, Oulton College and Collège communautaire du Nouveau-Brunswick. Dornan didn't say whether the province would renew the bursary program, but said they would "evaluate" its value.
Globe and Mail
36 minutes ago
- Globe and Mail
GME Earnings: GameStop Reports Mixed Financial Results and 4,710 Bitcoin
GameStop's (GME) share price is down about 5% after the video game retailer reported mixed first-quarter financial results. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter The Texas-based company announced earnings per share (EPS) of $0.09, which topped the $0.04 consensus expectation of analysts. However, revenue for the quarter came in at $732.4 million, which was below the consensus Wall Street estimate of $754.2 million. The company also reported an improved operating margin of -1.5%, which was up from -5.7% in the same quarter of 2024. GameStop's free cash flow at the end of the quarter totaled $189.6 million, which was a big improvement from negative -$114.7 million a year earlier. GameStop's profitability. Source: Main Street Data Bitcoin Purchases Along with its financial results, GameStop disclosed that it bought 4,710 Bitcoins (BTC) between May 3 and June 10 of this year. It's not known what the average purchase price of the Bitcoin was. However, GameStop's BTC holdings are currently worth $516.6 million based on the current price of Bitcoin. GameStop announced previously that it planned to begin buying and holding cryptocurrencies, adopting a similar playbook to that of software developer turned serial BTC acquirer Strategy (MSTR). GameStop has said it plans to use its excess cash to make investments in risk assets such as crypto and stocks. The company made its first Bitcoin investment in May of this year. Is GME Stock a Buy? Currently, only one Wall Street analysts offers a rating and price target on GME stock. So instead, we'll look at the stock's three-month performance. As one can see in the chart below, GameStop's share price has gained 33% over the last 12 weeks.
